Julian Adams

2013

In 2013, Julian Adams earned a total compensation of $2.7M as President of R&D at Infinity Pharmaceuticals, a 114% increase compared to previous year.

Compensation breakdown

Option Awards$2,183,700
Salary$465,800
Other$1,806
Total$2,651,306

Adams received $2.2M in option awards, accounting for 82% of the total pay in 2013.

Adams also received $465.8K in salary and $1.8K in other compensation.

Rankings

In 2013, Julian Adams' compensation ranked 2,926th out of 12,286 executives tracked by ExecPay. In other words, Adams earned more than 76.2% of executives.

ClassificationRankingPercentile
All
2,926
out of 12,286
76th
Division
Manufacturing
970
out of 4,612
79th
Major group
Chemicals And Allied Products
254
out of 1,462
83rd
Industry group
Drugs
172
out of 1,156
85th
Industry
Pharmaceutical Preparations
142
out of 890
84th
Source: SEC filing on April 25, 2016.

Adams' colleagues

We found four more compensation records of executives who worked with Julian Adams at Infinity Pharmaceuticals in 2013.

2013

Adelene Perkins

Infinity Pharmaceuticals

Chief Executive Officer

2013

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

2013

Lawrence Bloch

Infinity Pharmaceuticals

Chief Financial Officer

2013

David Roth

Infinity Pharmaceuticals

Chief Medical Officer

In-depth

You may also like